The Net Margin of Staidson Beijing BioPharmaceuticals Co Ltd (300204.SZ) is -44.59%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -44.59% |
| 2023-12-31 | -109.53% |
| 2022-12-31 | -35.89% |
| 2021-12-31 | -23.52% |
| 2020-12-31 | -31.28% |
| 2019-12-31 | 4.13% |
| 2018-12-31 | 16.64% |
| 2017-12-31 | 18.95% |
| 2016-12-31 | 18.34% |
| 2015-12-31 | 16.92% |